PRS21 Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in the Dominican Republic Public Case

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.305
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Time to Clinical Stability in Patients With Ventilator-Associated Pneumonia Due to Methicillin-Resistant Staphylococcus Aureus Treated With Linezolid Versus Vancomycin: Results From the IMPAC-HAP Study

Journal of Respiratory Infections
2017English

Risk Factors for Ventilator-Associated Pneumonia in Trauma Patients: A Descriptive Analysis

World Journal of Emergency Medicine
Emergency Medicine
2018English

Ventilator-Associated Pneumonia

Perspectives on Critical Care Infectious Diseases
2001English

Ventilator-Associated Pneumonia

The Professional Medical Journal
2018English

Prs28 - Cost of Illness Due to Bacterial Pneumonia in the Adult Population in Dominican Republic From a Public Perspective During 2018

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Ventilator-Associated Pneumonia

Respirology
PulmonaryRespiratory Medicine
2009English

Antibiotics for Ventilator-Associated Pneumonia

2010English

Toothbrushing for Preventing Ventilator-Associated Pneumonia

Critical Care
Critical CareIntensive Care Medicine
2013English

Cost-Effectiveness Evaluation of Linezolid, Vancomycin and Teicoplanin in Treating Nosocomial Pneumonia Caused by Methicilin Resistant Staphylococcus Aureus (Mrsa) – Private Health Care System Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy